10 /100
LOW RISK
Score updated Jul 13, 2026

CBT — Cabot Corporation Dilution Risk Tracker

Track CBT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CBT — Get alerts when the score changes →

As of July 13, 2026, Cabot Corporation (CBT) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Cabot Corporation has a market capitalization of $4.52B, 51.62M shares outstanding, 377 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
18
💰 Cash Runway
0
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CBT.
🔔 Track CBT — Get forecast alerts →

💹 Market Data

Market Cap$4.52B
Shares Outstanding51.62M
Float50.97M
Cash$253.00M
Debt$1.12B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 2.3% shares (2026Q1 vs prior)
377 institutional holders · 57.68M shares
#1 BlackRock, Inc. 6.62M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.65M shares
#3 WELLINGTON MANAGEMENT GROUP LLP 3.57M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.77M
Days to Cover4.3
% of Float7.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Apr 01, 2026
4 INSIDER TRANSACTION Mar 17, 2026
4 INSIDER TRANSACTION Mar 17, 2026
4 INSIDER TRANSACTION Mar 17, 2026
4 INSIDER TRANSACTION Mar 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CBT Shareholders

Cabot Corporation (CBT) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for CBT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CBT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CBT alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CBT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CBT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CBT
📊 CBT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CBT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.